Click on image to view larger version.

Figure 3 Cumulative Urinary Potassium Excretion During Dosing

Cumulative urinary potassium excretion (mEq) over the interval of 0 to 8 h at baseline and after placebo or BG9928 administration on days 1, 6, and 10. *p < 0.05 versus placebo. n = 10/group except for 15- and 75-mg dose groups on day 10 (n = 9/group).